SIONSionna Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Sionna Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SION본 종목 | $169M#4 | — | 0.6x#1 | — | — | -22.0%#5 | — | -28.3%#3 | — | — | -90.3%#5 | — |
| WHWK | $182M#1 | — | 1.0x#2 | 25.5x#2 | -72.5%#3 | 67.7%#1 | -1601.1%#2 | -11.3%#2 | — | — | 34.2%#2 | — |
| INO | $181M#2 | — | 41.4x#5 | 2769.2x#3 | -70.0%#2 | 20.6%#3 | -132871.3%#3 | -1944.6%#5 | -243.9%#2 | — | -25.5%#4 | — |
| ALXO | $176M#3 | — | 1.3x#3 | — | — | 24.6%#2 | — | -74.7%#4 | -84.4%#1 | — | -17.8%#3 | — |
| MGNX | $156M#5 | — | 3.6x#4 | 1.0x#1 | -0.3%#1 | -11.4%#4 | -48.7%#1 | -0.2%#1 | — | — | 48.8%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice